Riskpilot← Back to searchSign inGet full accessMedicape Oy
OYActiveY-tunnus 2075877-5Kaistareenkatu 5Medical specialists activities · NACE 8622Est. 20063 employees
Revenue 2024
EUR 543K
+4% vs 2023
EBITDA margin
46.4%
+155% vs 2023
Equity ratio
98.9%
Financial strength
Net profit 2024
EUR 213K
-8% vs 2023
| Revenue | EUR 543K | +4% |
| EBITDA | EUR 252K | +155% |
| Net profit | EUR 213K | -8% |
| Total assets | EUR 1M | +15% |
| Equity | EUR 1M | +16% |
| Employees | 3 | — |
Legal name
Medicape Oy
Y-tunnus number
2075877-5
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
21. marraskuuta 2006
Share capital
EUR 2 500
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Yhtiön toimiala on silmälääkäripalvelut ja edelliseen liittyvien palvelujen ja tavaroiden myynti. Yhtiö voi omistaa kiinteistöjä ja osakkeita ja käydä niillä kauppaa.
Address
Kaistareenkatu 5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 416 | 481 | 511 | 520 | 543 |
| Staff expenses | −205 | −187 | −194 | −395 | −264 |
| EBITDA | 195 | 266 | 292 | 99 | 252 |
| Depreciation & amort. | −9 | −18 | −13 | −22 | −16 |
| EBIT | 187 | 249 | 279 | 279 | 236 |
| Net financials | 5 | 9 | 12 | 15 | 31 |
| Profit before tax | 192 | 258 | 291 | 92 | 267 |
| Tax | 39 | 52 | 59 | 19 | 54 |
| Net profit | 153 | 206 | 232 | 232 | 213 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 648 | 804 | 944 | 904 | 1 039 |
| Equity | 545 | 707 | 883 | 885 | 1 028 |
| Long-term debt | 82 | 58 | 34 | 10 | 3 |
| Short-term debt | 21 | 38 | 28 | 9 | 9 |
| Total debt | 103 | 96 | 62 | 19 | 12 |
EBITDA margin
46.4%
This company
15.8%
Market median
+194% vs market
20202024
Equity ratio
98.9%
This company
38.2%
Market median
+159% vs market
20202024
Return on equity
20.7%
This company
18.4%
Market median
+13% vs market
20202024
Net profit margin
39.2%
This company
8.1%
Market median
+384% vs market
20202024
Asset turnover
0.52×
This company
1.12×
Market median
-54% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
SK | Audit | 2026 |
AT Deputy Member | Deputy Member | 2011 |
RE Deputy auditor | Deputy auditor | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2011 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medicape Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Silja Kristiina Ruusu | Audit | 0 companies |
| Anna-Mari Tuokko | Deputy Member | 0 companies |
| Reetta Emilia Ahonen | Deputy auditor | 0 companies |
| Juha Kalevi Tuokko | Board of Directors | 0 companies |